Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 120801, 8 pages
http://dx.doi.org/10.1155/2011/120801
Research Article

A Regenerative Antioxidant Protocol of Vitamin E and α-Lipoic Acid Ameliorates Cardiovascular and Metabolic Changes in Fructose-Fed Rats

1School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia
2Department of Biological and Physical Sciences, University of Southern Queensland, Toowoomba, QLD 4350, Australia

Received 17 June 2010; Revised 27 December 2010; Accepted 2 January 2011

Copyright © 2011 Jatin Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Miller and K. Adeli, “Dietary fructose and the metabolic syndrome,” Current Opinion in Gastroenterology, vol. 24, no. 2, pp. 204–209, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. V. Thirunavukkarasu, A. T. Anitha Nandhini, and C. V. Anuradha, “Effect of α-lipoic acid on lipid profile in rats fed a high-fructose diet,” Experimental Diabesity Research, vol. 5, no. 3, pp. 195–200, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Vasdev, L. Longerich, and V. Gill, “Prevention of fructose-induced hypertension by dietary vitamins,” Clinical Biochemistry, vol. 37, no. 1, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Lee, W. R. Bruce, Q. Dong, J. Bruce, R. Mehta, and P. J. O'Brien, “Fructose and carbonyl metabolites as endogenous toxins,” Chemico-Biological Interactions, vol. 178, no. 1–3, pp. 332–339, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. M. Abdullah, N. N. Riediger, Q. Chen et al., “Effects of long-term consumption of a high-fructose diet on conventional cardiovascular risk factors in sprague-dawley rats,” Molecular and Cellular Biochemistry, vol. 327, no. 1-2, pp. 247–256, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Patel, A. Iyer, and L. Brown, “Evaluation of the chronic complications of diabetes in a high fructose diet in rats,” Indian Journal of Biochemistry and Biophysics, vol. 46, no. 1, pp. 66–72, 2009. View at Google Scholar · View at Scopus
  7. I. M. Liu, T. F. Tzeng, and S. S. Liou, “A Chinese herbal decoction, Dang Gui Bu Xue Tang, prepared from Radix Astragali and Radix Angelicae sinensis, ameliorates insulin resistance induced by a high-fructose diet in rats,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar · View at PubMed
  8. D. Song, S. Hutchings, and C. C. Y. Pang, “Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats,” European Journal of Pharmacology, vol. 508, no. 1–3, pp. 205–210, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. I. Hininger-Favier, R. Benaraba, S. Coves, R. A. Anderson, and A. M. Roussel, “Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat,” Journal of the American College of Nutrition, vol. 28, no. 4, pp. 355–361, 2009. View at Google Scholar · View at Scopus
  10. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. J. Chess, W. Xu, R. Khairallah et al., “The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet,” American Journal of Physiology, vol. 295, no. 6, pp. H2223–H2230, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. Oudot, D. Behr-Roussel, S. Compagnie et al., “Endothelial dysfunction in insulin-resistant rats is associated with oxidative stress and COX pathway dysregulation,” Physiological Research, vol. 58, no. 4, pp. 499–509, 2009. View at Google Scholar · View at Scopus
  13. N. Palanisamy, P. Viswanathan, and C. V. Anuradha, “Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet,” Renal Failure, vol. 30, no. 6, pp. 645–654, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. W. Clarke, J. R. Burnett, and K. D. Croft, “Vitamin E in human health and disease,” Critical Reviews in Clinical Laboratory Sciences, vol. 45, no. 5, pp. 417–450, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. J. Bell and G. T. Grochoski, “How safe is vitamin e supplementation?” Critical Reviews in Food Science and Nutrition, vol. 48, no. 8, pp. 760–774, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. D. Wollin and P. J. H. Jones, “α-Lipoic acid and cardiovascular disease,” Journal of Nutrition, vol. 133, no. 11, pp. 3327–3330, 2003. View at Google Scholar · View at Scopus
  17. J. L. Evans and I. D. Goldfine, “α-Lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes,” Diabetes Technology and Therapeutics, vol. 2, no. 3, pp. 401–413, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Sena, E. Nunes, T. Louro et al., “Effects of α-lipoic acid on endothelial function in aged diabetic and high-fat fed rats,” British Journal of Pharmacology, vol. 153, no. 5, pp. 894–906, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. S. Coombes, S. K. Powers, K. L. Hamilton et al., “Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and α-lipoic acid,” American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 279, no. 6, pp. R2149–R2155, 2000. View at Google Scholar · View at Scopus
  20. A. Fenning, G. Harrison, R. Rose'meyer, A. Hoey, and L. Brown, “L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats,” American Journal of Physiology, vol. 289, no. 4, pp. H1408–H1416, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. G. Miric, C. Dallemagne, Z. Endre, S. Margolin, S. M. Taylor, and L. Brown, “Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats,” British Journal of Pharmacology, vol. 133, no. 5, pp. 687–694, 2001. View at Google Scholar · View at Scopus
  22. S. Levick, D. Loch, B. Rolfe et al., “Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A in young spontaneously hypertensive rats,” Journal of Immunology, vol. 176, no. 11, pp. 7000–7007, 2006. View at Google Scholar · View at Scopus
  23. V. Thirunavukkarasu, A. T. Anitha Nandhini, and C. V. Anuradha, “Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats,” Journal of Comparative Physiology B, vol. 174, no. 8, pp. 587–592, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. T. Kizhner and M. J. Werman, “Long-term fructose intake: biochemical consequences and altered renal histology in the male rat,” Metabolism, vol. 51, no. 12, pp. 1538–1547, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. I. Hwang, H. Ho, B. B. Hoffman, and G. M. Reaven, “Fructose-induced insulin resistance and hypertension in rats,” Hypertension, vol. 10, no. 5, pp. 512–516, 1987. View at Google Scholar · View at Scopus
  26. B. A. Maddux, W. See, J. C. Lawrence Jr., A. L. Goldfine, I. D. Goldfine, and J. L. Evans, “Protection against oxidative stress-induced insulin resistance in rat l6 muscle cells by micromolar concentrations of α-lipoic acid,” Diabetes, vol. 50, no. 2, pp. 404–410, 2001. View at Google Scholar · View at Scopus
  27. A. Rudich, A. Tlrosh, R. Potashnik, R. Hemi, H. Kanety, and N. Bashan, “Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes,” Diabetes, vol. 47, no. 10, pp. 1562–1569, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Fiordaliso, R. Bianchi, L. Staszewsky et al., “Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats,” Journal of Molecular and Cellular Cardiology, vol. 37, no. 5, pp. 959–968, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. Iyer and L. Brown, “Fermented wheat germ extract (Avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 508957, 10 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  30. J. Z. Luo and L. Luo, “Ginseng on hyperglycemia: effects and mechanisms,” Evidence-Based Complementary and Alternative Medicine, vol. 6, pp. 423–427, 2009. View at Google Scholar
  31. S. B. Sharma, R. Rajpoot, A. Nasir, K. M Prabhu, and P. S. Murthy, “Ameliorative effect of active principle isolated from seeds of Eugenia Jambolana on carbohydrate metabolism in experimental diabetes,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar · View at PubMed
  32. B. Qin, M. Nagasaki, M. Ren, G. Bajotto, Y. Oshida, and Y. Sato, “Gosha-jinki-gan (a herbal complex) corrects abnormal insulin signaling,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 269–276, 2004. View at Google Scholar
  33. K.-H. Song, W. J. Lee, J.-M. Koh et al., “α-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats,” Biochemical and Biophysical Research Communications, vol. 326, no. 1, pp. 197–202, 2004. View at Publisher · View at Google Scholar · View at PubMed
  34. H. Kaneto, Y. Kajimoto, J. I. Miyagawa et al., “Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity,” Diabetes, vol. 48, no. 12, pp. 2398–2406, 1999. View at Google Scholar · View at Scopus
  35. L. Franzini, D. Ardigò, and I. Zavaroni, “Dietary antioxidants and glucose metabolism,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 11, no. 4, pp. 471–476, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. Y. Minamiyama, S. Takemura, T. Tsukioka et al., “Effect of AOB, a fermented-grain food supplement, on oxidative stress in type 2 diabetic rats,” BioFactors, vol. 30, no. 2, pp. 91–104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Thirunavukkarasu and C. V. Anuradha, “Influence of α-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats,” Diabetes, Obesity and Metabolism, vol. 6, no. 3, pp. 200–207, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. A. Lexis, A. Fenning, L. Brown, R. G. Fassett, and J. S. Coombes, “Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction,” American Journal of Transplantation, vol. 6, no. 1, pp. 41–49, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. K. Kawano, T. Hirashima, S. Mori, and T. Natori, “OLETF (Otsuka Long-Evans Tokushima fatty) rat: a new NIDDM rat strain,” Diabetes Research and Clinical Practice, vol. 24, pp. S317–S320, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Tay, A. T. Özçelikay, and V. M. Altan, “Effects of L-arginine on blood pressure and metabolic changes in fructose-hypertensive rats,” American Journal of Hypertension, vol. 15, no. 1, pp. 72–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. R. Gaby, “Adverse effects of dietary fructose,” Alternative Medicine Review, vol. 10, no. 4, pp. 294–306, 2005. View at Google Scholar · View at Scopus
  43. M. F. Sorrell and D. J. Tuma, “The functional implications of acetaldehyde binding to cell constituents,” Annals of the New York Academy of Sciences, vol. 492, pp. 50–62, 1987. View at Google Scholar · View at Scopus
  44. A. Sharma, S. Kharb, S. N. Chugh, R. Kakkar, and G. P. Singh, “Effect of glycemic control and vitamin E supplementation on total glutathione content in non-insulin-dependent diabetes mellitus,” Annals of Nutrition and Metabolism, vol. 44, no. 1, pp. 11–13, 2000. View at Google Scholar · View at Scopus
  45. A. Meister, M. E. Anderson, and O. Hwang, “Intracellular cysteine and glutathione delivery systems,” Journal of the American College of Nutrition, vol. 5, no. 2, pp. 137–151, 1986. View at Google Scholar · View at Scopus
  46. S. Jacob, R. S. Streeper, D. L. Fogt et al., “The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle,” Diabetes, vol. 45, no. 8, pp. 1024–1029, 1996. View at Google Scholar · View at Scopus
  47. S. Vasdev, C. A. Ford, S. Parai, L. Longerich, and V. Gadag, “Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 10, no. 6, pp. 339–346, 2000. View at Google Scholar · View at Scopus
  48. P. A. Kroon, A. Iyer, P. Chunduri, V. Chan, and L. Brown, “The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential,” Current Medicinal Chemistry, vol. 17, no. 23, pp. 2442–2455, 2010. View at Publisher · View at Google Scholar
  49. C. A. Hamilton, W. H. Miller, S. Al-Benna et al., “Strategies to reduce oxidative stress in cardiovascular disease,” Clinical Science, vol. 106, no. 3, pp. 219–234, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. M. C. Houston, “Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension,” Progress in Cardiovascular Diseases, vol. 47, no. 6, pp. 396–449, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. C. A. Roncal, S. Reungjui, L. G. Sánchez-Lozada et al., “Combination of captopril and allopurinol retards fructose-induced metabolic syndrome,” American Journal of Nephrology, vol. 30, no. 5, pp. 399–404, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. C. A. Di Verniero, E. A. Silberman, M. A. Mayer, J. A. W. Opezzo, C. A. Taira, and C. Höcht, “In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats,” Journal of Cardiovascular Pharmacology, vol. 51, no. 6, pp. 532–541, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus